PPA
XFOR icon

Parametric Portfolio Associates’s X4 Pharmaceuticals XFOR Stock Holding History

Parametric Portfolio Associates’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-140
Closed -$59K – 3981
2018
Q4 		$59K Buy
+140
New +$53.4K ﹤0.01% 3835

Other funds holding XFOR

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Parametric Portfolio Associates's XFOR Position: Q1 2019 in Review

Parametric Portfolio Associates sold out of X4 Pharmaceuticals (XFOR) in Q1 2019, closing a stake of 140 shares — an estimated $59K sold.

Parametric Portfolio Associates first reported a position in XFOR in Q4 2018 and held it in 1 quarter. The position peaked at $59K in Q4 2018. 29 funds tracked by Wall St. Rank hold XFOR as of Q1 2019.

  • Parametric Portfolio Associates reported no remaining X4 Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Parametric Portfolio Associates sold 140 X4 Pharmaceuticals shares in Q1 2019, an estimated $59K.
  • Parametric Portfolio Associates first reported a position in X4 Pharmaceuticals in Q4 2018 and held it in 1 quarter.
  • Parametric Portfolio Associates's X4 Pharmaceuticals position peaked at $59K in Q4 2018.
  • 29 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q1 2019.

Based on Parametric Portfolio Associates's 13F filing for Q1 2019, filed 9 May 2019.